Health Canada
- Status: approved
🇨🇦 Mepolizumab 300 mg in Canada
Mepolizumab 300 mg (Mepolizumab 300 mg) regulatory status in Canada.
Marketing authorisation
Mepolizumab 300 mg in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Mepolizumab 300 mg approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for Mepolizumab 300 mg in Canada?
Azienda Ospedaliero Universitaria di Cagliari is the originator. The local marketing authorisation holder may differ — check the official source linked above.